These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3530620)

  • 21. Long-term therapy with sustained-release theophylline.
    Myhre KI; Arnulf V; Walstad RA
    Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The hemodynamic effects of reproterol in patients with chronic obstructive lung disease (author's transl)].
    Bonaduce D; Ferrara N; Canonico V; Cocozza M; Petretta M; Romano E; Rengo F
    G Ital Cardiol; 1981; 11(10):1467-71. PubMed ID: 7341317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutical effect of a new antidyspnoeic drug in the chronic obstructive pulmonary disease (author's transl)].
    Chillón F
    Folia Clin Int (Barc); 1973 Jun; 23(6):464-76. PubMed ID: 4805350
    [No Abstract]   [Full Text] [Related]  

  • 24. Continuous treatment of asthmatic patients with enprofylline and theophylline.
    Laursen LC; Johannesson N; Weeke B
    Eur J Respir Dis; 1984 Oct; 65(7):504-8. PubMed ID: 6386511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Theophylline and selective phosphodiesterase inhibitor in therapy of obstructive respiratory tract diseases].
    Rabe KF; Dent G; Magnussen H
    Pneumologie; 1997 Mar; 51(3):303-16. PubMed ID: 9173421
    [No Abstract]   [Full Text] [Related]  

  • 26. Theophylline in the treatment of the elderly with chronic obstructive pulmonary disease.
    Antognozzi G; Buzzo P; Mori M; Ellena S; Triolo A
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):69-72. PubMed ID: 7480962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic effect of bronchospasmin in bronchial asthma patients].
    Kosturkov G; Staneva M; Vŭlcheva T; Mileva Zh; Gaĭtandzhiev K
    Vutr Boles; 1983; 22(4):46-9. PubMed ID: 6372247
    [No Abstract]   [Full Text] [Related]  

  • 28. The position of theophylline in the treatment of asthma and chronic obstructive pulmonary disease.
    Dekhuijzen PN; van der Heijden HF; van Herwaarden CL
    Neth J Med; 1995 May; 46(5):213-6. PubMed ID: 7783821
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of ventilation changes in patients with obstructive bronchopneumopathy induced by bronchodilator drugs].
    De Benedetto F; Cervone M; De Blasio E; D'Ilario F; Fuciarelli R; Luciano A; Sborgia M
    Clin Ter; 1984 Jun; 109(6):509-17. PubMed ID: 6236941
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation using dynamic ECG of the effects of reproterol (a new beta-2 adrenergic receptor agonist) on the heart conduction system].
    Citone C; Carelli M; Di Marcotullio G; Tubaro M; Milazzotto F
    Clin Ter; 1984 Sep; 110(5):429-36. PubMed ID: 6149836
    [No Abstract]   [Full Text] [Related]  

  • 31. [Broncholytic effect of Atrovent in comparison with a combination preparation in obstructive lung diseases].
    Holzhey P
    Wien Med Wochenschr; 1975 Dec; 125(49):711-6. PubMed ID: 1229127
    [No Abstract]   [Full Text] [Related]  

  • 32. [A strategy of drug treatment of obstructive respiratory tract diseases].
    Slapke J; Adolph J
    Z Arztl Fortbild (Jena); 1989; 83(17):857-9. PubMed ID: 2686213
    [No Abstract]   [Full Text] [Related]  

  • 33. [Increase of arterial oxygen pressure in therapy with theophylline in patients with obstructive ventilation disorder and partial respiratory insufficiency].
    Schmidt EW; Ulmer WT
    Prax Klin Pneumol; 1988 Jul; 42(7):600-2. PubMed ID: 3054862
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D
    Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of bronchodilators in the therapy of obstructive respiratory diseases].
    Fortschr Med; 1983 Mar; 101(10):435-6. PubMed ID: 6840647
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pirenzepine in the prevention of gastric intolerance to drugs used in pulmonary pathology].
    Guarino C; Cautiero V; Borrelli G; De los Rios B; Marcatili S; Valentini P
    Minerva Dietol Gastroenterol; 1988; 34(2):129-34. PubMed ID: 3050611
    [No Abstract]   [Full Text] [Related]  

  • 38. Theophylline-induced stuttering.
    Gérard JM; Delecluse F; Robience Y
    Mov Disord; 1998 Sep; 13(5):847-8. PubMed ID: 9756159
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
    Riddington CJ; Shipman AJ
    Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bronchodilator effect of methylxanthine derivatives (author's transl)].
    Werdermann K; Jorde W
    Dtsch Med Wochenschr; 1979 Sep; 104(37):1307-11. PubMed ID: 477550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.